79 related articles for article (PubMed ID: 26671023)
1. Assessing the Cumulative Contribution of New and Established Common Genetic Risk Factors to Early-Onset Prostate Cancer.
Lange EM; Ribado JV; Zuhlke KA; Johnson AM; Keele GR; Li J; Wang Y; Duan Q; Li G; Gao Z; Li Y; Xu J; Zheng SL; Cooney KA
Cancer Epidemiol Biomarkers Prev; 2016 May; 25(5):766-72. PubMed ID: 26671023
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide association scan for variants associated with early-onset prostate cancer.
Lange EM; Johnson AM; Wang Y; Zuhlke KA; Lu Y; Ribado JV; Keele GR; Li J; Duan Q; Li G; Gao Z; Li Y; Xu J; Isaacs WB; Zheng S; Cooney KA
PLoS One; 2014; 9(4):e93436. PubMed ID: 24740154
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the SRD5A2 gene and the risk of prostate cancer.
Dušenka R; Tomaškin R; Kliment J; Dobrota D; Dušenková S; Vilčková M; Sivoňová MK
Mol Med Rep; 2014 Dec; 10(6):3151-6. PubMed ID: 25310105
[TBL] [Abstract][Full Text] [Related]
4. Sequence variants of Toll-like receptor 4 and susceptibility to prostate cancer.
Chen YC; Giovannucci E; Lazarus R; Kraft P; Ketkar S; Hunter DJ
Cancer Res; 2005 Dec; 65(24):11771-8. PubMed ID: 16357190
[TBL] [Abstract][Full Text] [Related]
5. Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSA.
Severi G; Hayes VM; Neufing P; Padilla EJ; Tilley WD; Eggleton SA; Morris HA; English DR; Southey MC; Hopper JL; Sutherland RL; Boyle P; Giles GG
Cancer Epidemiol Biomarkers Prev; 2006 Jun; 15(6):1142-7. PubMed ID: 16775173
[TBL] [Abstract][Full Text] [Related]
6. Oxidative stress-related genetic variants, pro- and antioxidant intake and status, and advanced prostate cancer risk.
Geybels MS; van den Brandt PA; van Schooten FJ; Verhage BA
Cancer Epidemiol Biomarkers Prev; 2015 Jan; 24(1):178-86. PubMed ID: 25315963
[TBL] [Abstract][Full Text] [Related]
7. P53 codon 72 (Arg72Pro) polymorphism and prostate cancer risk: association between disease onset and proline genotype.
Rogler A; Rogenhofer M; Borchardt A; Lunz JC; Knoell A; Hofstaedter F; Tannapfel A; Wieland W; Hartmann A; Stoehr R
Pathobiology; 2011; 78(4):193-200. PubMed ID: 21778786
[TBL] [Abstract][Full Text] [Related]
8. Prostate cancer risk variants are not associated with disease progression.
Szulkin R; Holmberg E; Stattin P; Xu J; Zheng S; Palmgren J; Grönberg H; Wiklund F
Prostate; 2012 Jan; 72(1):30-9. PubMed ID: 21520160
[TBL] [Abstract][Full Text] [Related]
9. Germline mutations in the BRCA2 gene and susceptibility to hereditary prostate cancer.
Agalliu I; Kwon EM; Zadory D; McIntosh L; Thompson J; Stanford JL; Ostrander EA
Clin Cancer Res; 2007 Feb; 13(3):839-43. PubMed ID: 17289875
[TBL] [Abstract][Full Text] [Related]
10. Genetic predisposition to early recurrence in clinically localized prostate cancer.
Borque Á; del Amo J; Esteban LM; Ars E; Hernández C; Planas J; Arruza A; Llarena R; Palou J; Herranz F; Raventós CX; Tejedor D; Artieda M; Simon L; Martínez A; Carceller E; Suárez M; Allué M; Sanz G; Morote J
BJU Int; 2013 Apr; 111(4):549-58. PubMed ID: 22759231
[TBL] [Abstract][Full Text] [Related]
11. Association of THADA, FOXP4, GPRC6A/RFX6 genes and 8q24 risk alleles with prostate cancer in Northern Chinese men.
Li XH; Xu Y; Yang K; Shi JJ; Zhang X; Yang F; Yuan H; Zhu X; Zhang YH; Wang JY; Yang Z
J BUON; 2015; 20(5):1223-8. PubMed ID: 26537068
[TBL] [Abstract][Full Text] [Related]
12. Sequence variation in alpha-methylacyl-CoA racemase and risk of early-onset and familial prostate cancer.
Levin AM; Zuhlke KA; Ray AM; Cooney KA; Douglas JA
Prostate; 2007 Oct; 67(14):1507-13. PubMed ID: 17683075
[TBL] [Abstract][Full Text] [Related]
13. Sequence variants of alpha-methylacyl-CoA racemase are associated with prostate cancer risk: a replication study in an ethnically homogeneous population.
FitzGerald LM; Thomson R; Polanowski A; Patterson B; McKay JD; Stankovich J; Dickinson JL
Prostate; 2008 Sep; 68(13):1373-9. PubMed ID: 18537123
[TBL] [Abstract][Full Text] [Related]
14. The presence of prostate cancer at biopsy is predicted by a number of genetic variants.
Kashyap A; Kluźniak W; Wokołorczyk D; Gołąb A; Sikorski A; Słojewski M; Gliniewicz B; Świtała J; Borkowski T; Borkowski A; Antczak A; Wojnar Ł; Przybyła J; Sosnowski M; Małkiewicz B; Zdrojowy R; Sikorska-Radek P; Matych J; Wilkosz J; Różański W; Kiś J; Bar K; Bryniarski P; Paradysz A; Jersak K; Niemirowicz J; Słupski P; Jarzemski P; Skrzypczyk M; Dobruch J; Domagała P; Piotrowski K; Jakubowska A; Gronwald J; Huzarski T; Byrski T; Dębniak T; Górski B; Masojć B; van de Wetering T; Menkiszak J; Akbari MR; Lubiński J; Narod SA; Cybulski C;
Int J Cancer; 2014 Mar; 134(5):1139-46. PubMed ID: 24037955
[TBL] [Abstract][Full Text] [Related]
15. Sequence variants in the TLR4 and TLR6-1-10 genes and prostate cancer risk. Results based on pooled analysis from three independent studies.
Lindström S; Hunter DJ; Grönberg H; Stattin P; Wiklund F; Xu J; Chanock SJ; Hayes R; Kraft P
Cancer Epidemiol Biomarkers Prev; 2010 Mar; 19(3):873-6. PubMed ID: 20200442
[TBL] [Abstract][Full Text] [Related]
16. Zinc α2-glycoprotein as a potential novel urine biomarker for the early diagnosis of prostate cancer.
Katafigiotis I; Tyritzis SI; Stravodimos KG; Alamanis C; Pavlakis K; Vlahou A; Makridakis M; Katafigioti A; Garbis SD; Constantinides CA
BJU Int; 2012 Dec; 110(11 Pt B):E688-93. PubMed ID: 23020913
[TBL] [Abstract][Full Text] [Related]
17. Utility of incorporating genetic variants for the early detection of prostate cancer.
Nam RK; Zhang WW; Trachtenberg J; Seth A; Klotz LH; Stanimirovic A; Punnen S; Venkateswaran V; Toi A; Loblaw DA; Sugar L; Siminovitch KA; Narod SA
Clin Cancer Res; 2009 Mar; 15(5):1787-93. PubMed ID: 19223501
[TBL] [Abstract][Full Text] [Related]
18. Clinical implications of old and new genes for open-angle glaucoma.
Ramdas WD; van Koolwijk LM; Cree AJ; Janssens AC; Amin N; de Jong PT; Wolfs RC; Gibson J; Kirwan JF; Hofman A; Rivadeneira F; Oostra BA; Uitterlinden AG; Ennis S; Lotery AJ; Lemij HG; Klaver CC; Vingerling JR; Jansonius NM; van Duijn CM
Ophthalmology; 2011 Dec; 118(12):2389-97. PubMed ID: 21872936
[TBL] [Abstract][Full Text] [Related]
19. Does genotyping of risk-associated single nucleotide polymorphisms improve patient selection for prostate biopsy when combined with a prostate cancer risk calculator?
Butoescu V; Ambroise J; Stainier A; Dekairelle AF; Gala JL; Tombal B
Prostate; 2014 Apr; 74(4):365-71. PubMed ID: 24265090
[TBL] [Abstract][Full Text] [Related]
20. The rs743572 common variant in the promoter of CYP17A1 is not associated with prostate cancer risk or circulating hormonal levels.
Severi G; Hayes VM; Tesoriero AA; Southey MC; Hoang HN; Padilla EJ; Morris HA; English DR; Sutherland RL; Boyle P; Hopper JL; Giles GG
BJU Int; 2008 Feb; 101(4):492-6. PubMed ID: 17986287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
